Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched Boehringer’s One Medicine platform to help the German pharma streamline its product ...

In a country where almost everything can be delivered within minutes, waiting 24-48 hours for essential medicines is a challenge that many Indians continue to face. Repill, a health-tech startup based ...

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...

"Veeva Development Cloud provides the technology foundation for Boehringer's One Medicine Platform, giving our teams the flexibility to design and run studies with greater speed, efficiency ...

London, UK — 11 March 2025 — Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of ...

Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, ...

March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation ...

Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases "By connecting clinical, regulatory, and quality on Veeva Development ...